Takahiro Oike

KIF5B-RET fusions in lung adenocarcinoma

Takashi Kohno, Hitoshi Ichikawa, Yasushi Totoki et al. · Nature Medicine · 2012 · 827 citations · Full text

Tumor Biology, Lung Adenocarcinoma, Tumor Suppressor +5

DNA double-strand break repair pathway regulates PD-L1 expression in cancer cells

Hiro Sato, Atsuko Niimi, Takaaki Yasuhara et al. · Nature Communications · 2017 · 683 citations · Full text

Tumor Biology, Genome Instability, Cell Regulation +13

<scp>PD</scp>‐L1 expression is mainly regulated by interferon gamma associated with <scp>JAK</scp>‐<scp>STAT</scp> pathway in gastric cancer

Kousaku Mimura, Jun Liang Teh, Hirokazu Okayama et al. · Cancer Science · 2017 · 314 citations · Full text

A Synthetic Lethality–Based Strategy to Treat Cancers Harboring a Genetic Deficiency in the Chromatin Remodeling Factor BRG1

Takahiro Oike, Hideaki Ogiwara, Yuichi Tominaga et al. · Cancer Research · 2013 · 292 citations · Full text

Fgfr1 Gene Amplifications, Treat Cancers, Tumor Biology +19

Targeting p300 Addiction in <i>CBP</i> -Deficient Cancers Causes Synthetic Lethality by Apoptotic Cell Death due to Abrogation of <i>MYC</i> Expression

Hideaki Ogiwara, Mariko Sasaki, Takafumi Mitachi et al. · Cancer Discovery · 2015 · 179 citations · Full text